USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Search results for: 'endpoint security industry global 2024 2025'
- Did you mean
- endpoint security industry global 2014 2014
- endpoint security industry global 2014 2025
- Related search terms
- global market for smart handheld metrology devices forecast to 2023 industry research analysis made measurement amp instrumentation
- global water atomized copper powder market report 2020 by key players types applications countries market size forecast to 2026 based on 2020 covid19 worldwide spread
- global condition monitoring equipment market forecast to (20(2013 global) electric motors and electric drives market outlook 2020
- 2024 Frost & Sullivan Customer Value Leadership Award - The Global Watermarking Services Market
- 2025 china servic operating system industry market research report
-
16 Dec 2025 | Europe | Market Outlook
Top 10 Growth Opportunities in the European Life Sciences Industry, 2026
Transformational Policies Will Unlock Life Sciences Growth in 2026 Through AI-Enabled Innovation, Digital-Clinical Scale-Up, and Biomanufacturing Resilience
Europe’s life sciences sector is approaching a defining inflection point in 2026, as major regulatory and policy reforms converge to reshape pharma, diagnostics, life sciences IT, biotechnology, and the bioeconomy. Together, these frameworks open clear growth pathways across the value chain: the Clinical Trials Regulation (CTR) and European Health ...
$2,450.00 -
12 Apr 2018 | Europe | Market Research
Global Biologics Contract Development & Manufacturing Organization (CDMO) Market—Companies-to-Action
Establishment of Need-based Business Models with Advancements in Manufacturing Techniques is Driving Market Growth
The study on the "Global Biologics Contract Development & Manufacturing Organizations (CDMO) Market: Companies-to-Action" presents an overview of the global biologics development and manufacturing landscape with an emphasis on the seven leading CDMOs in the market. The study highlights the shifting focus and investments of bio-pharma companies towa...
$3,000.00
